Pharma companies that outsource their processes to just a few service providers can save product and process knowledge throughout the entire value chain. With the help of know-how gained from successfully completed development projects, clinical manufacturing processes can also be transferred more easily to commercial production, thereby shortening process planning, avoiding unnecessary redundancies and reducing both risk and costs.
Planning: The sooner the better
The establishment of a partnership with an experienced CDMO early in the process can often make the difference. The sooner and more carefully the entire production process is planned, the more value can be maximized from the overall drug package.